THE MUSCLE POWER STUDY: Surgery related muscle loss and muscle strength after complex abdominal surgery for pseudomyxoma peritonei, pancreatic, liver and colorectal cancer
- Conditions
- • pseudomyxoma peritonei (PMP)• liver tumor (primary cancer or colorectal liver metastases)• pancreatic cancer• bile duct cancer • colorectal cancer
- Registration Number
- NL-OMON28560
- Lead Sponsor
- This work is supported by a grant from the UMCG Cancer Research Foundation (Institutional Foundation for Cancer Research and Development). The study protocol has not undergone any peer-review by this funding body, nor will they play a role in the analysis and interpretation of the data.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 178
In order to be eligible to participate in this study, a patient must meet all of the following inclusion criteria:
•Age = 18 years;
•Able to read and understand the Dutch language;
•Diagnosed or the suspicion of a liver tumor (primary cancer or colorectal liver metastases), pancreatic malignancy, bile duct malignancy, colon tumor, rectum tumor, or pseudomyxoma peritonei;
•Scheduled to undergo elective open major abdominal surgery at UMCG, consisting of the following surgical procedures:
ocytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy (CRS with HIPEC);
o(sub)total pelvic exenteration;
opylorus preserving pancreaticoduodenectomy (PPPD);
owhipple procedure (classic pancreaticoduodenectomy);
o(sub)total pancreatectomy; or
omajor liver resection defined as =3 liver segments.
•Presence of a preoperative computed tomography (CT) of the abdomen to determine sarcopenia preoperatively;
•Has given informed consent to participate in the study.
A potential eligible patient who meets any of the following exclusion criteria will be excluded from participation in this study:
•Scheduled to undergo emergency resection;
•Scheduled to undergo laparoscopic surgery;
•Scheduled to undergo minor liver resections (defined as <3 liver segments);
•Inability to co-operate and give informed consent.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method